Dimensional Fund Advisors’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding LENZ
7IH
Dimensional Fund Advisors's LENZ Position: Q3 2026 in Review
Dimensional Fund Advisors held its LENZ Therapeutics (LENZ) position steady in Q3 2026 at 24,892 shares worth $95.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3135.
Dimensional Fund Advisors first reported a position in LENZ in Q3 2022 and has held it in 17 quarters since. The position peaked at $1.9M in Q3 2025. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.
- Dimensional Fund Advisors held 24,892 shares of LENZ Therapeutics worth $95.6K as of Q3 2026.
- Dimensional Fund Advisors left its LENZ Therapeutics share count unchanged in Q3 2026.
- LENZ Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3135 holding.
- Dimensional Fund Advisors first reported a position in LENZ Therapeutics in Q3 2022 and has held it in 17 quarters since.
- Dimensional Fund Advisors's LENZ Therapeutics position peaked at $1.9M in Q3 2025.
- 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.